Last Updated

12 Aug 2022

WHO technical consultation to review the role of drugs in malaria prevention for people living in endemic settings

Click on the image above to open the resource:

WHO technical consultation to review the role of drugs in malaria prevention for people living in endemic settings

On 16–17 October 2019, WHO convened a Technical Consultation to review the use of medicines for malaria prevention in endemic countries and to identify opportunities to increase their impact through review of the flexibility of the recommendations for their deployment. Experts reviewed the policies and use of chemoprevention as currently endorsed by WHO, including intermittent preventive treatment in pregnancy (IPTp), intermittent preventive treatment in infants (IPTi), seasonal malaria chemoprevention (SMC) and mass drug administration (MDA) for the reduction of disease burden in emergency situations. By reviewing these strategies side-by-side for the first time, the meeting was able to consider opportunities for optimization. Additional potential applications of chemoprevention were also reviewed, and key considerations identified to develop a broader role for malaria chemoprevention in malaria-endemic populations.

The resource is also available in Français.